Filing Details
- Accession Number:
- 0001127602-22-025172
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-09 15:15:33
- Reporting Period:
- 2022-11-07
- Accepted Time:
- 2022-11-09 15:15:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
821189 | Eog Resources Inc | EOG | Crude Petroleum & Natural Gas (1311) | 470684736 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1376006 | P Michael Donaldson | 1111 Bagby, Sky Lobby 2 Houston TX 77002 | Evp, Gen. Counsel & Corp Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-11-07 | 12,056 | $127.00 | 125,799 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-11-07 | 10,490 | $145.97 | 115,309 | No | 4 | D | Direct | |
Common Stock | Disposition | 2022-11-07 | 616 | $145.97 | 114,693 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2022-11-07 | 4,160 | $75.09 | 118,853 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-11-07 | 2,140 | $145.97 | 116,713 | No | 4 | D | Direct | |
Common Stock | Disposition | 2022-11-07 | 795 | $145.97 | 115,918 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2022-11-07 | 4,074 | $37.44 | 119,992 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-11-07 | 1,045 | $145.97 | 118,947 | No | 4 | D | Direct | |
Common Stock | Disposition | 2022-11-07 | 1,192 | $145.97 | 117,755 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2022-11-07 | 4,074 | $81.81 | 121,829 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-11-07 | 2,284 | $145.97 | 119,545 | No | 4 | D | Direct | |
Common Stock | Disposition | 2022-11-07 | 704 | $145.97 | 118,841 | No | 4 | F | Direct | |
Common Stock | Disposition | 2022-11-08 | 4,465 | $148.00 | 114,376 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Appreciation Rights | Disposition | 2022-11-07 | 12,056 | $0.00 | 12,056 | $127.00 |
Common Stock | Stock Appreciation Rights | Disposition | 2022-11-07 | 4,160 | $0.00 | 4,160 | $75.09 |
Common Stock | Stock Appreciation Rights | Disposition | 2022-11-07 | 4,074 | $0.00 | 4,074 | $37.44 |
Common Stock | Stock Appreciation Rights | Disposition | 2022-11-07 | 4,074 | $0.00 | 4,074 | $81.81 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2019-09-27 | 2025-09-27 | No | 4 | M | Direct |
0 | 2022-09-26 | 2026-09-26 | No | 4 | M | Direct |
4,087 | 2022-09-28 | 2027-09-28 | No | 4 | M | Direct |
8,161 | 2022-09-27 | 2028-09-27 | No | 4 | M | Direct |
Footnotes
- The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 27, 2018 date of grant. The SARs granted became fully exercisable on September 27, 2021. This exercise did not involve any open-market sale of the Issuer's Common Stock.
- The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 26, 2019 date of grant. The SARs granted became fully exercisable on September 26, 2022. This exercise did not involve any open-market sale of the Issuer's Common Stock.
- The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted will become fully exercisable on September 28, 2023. This exercise did not involve any open-market sale of the Issuer's Common Stock.
- The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 27, 2021 date of grant. The SARs granted will become fully exercisable on September 27, 2024. This exercise did not involve any open-market sale of the Issuer's Common Stock.